BANCR-containing extracellular vesicles enhance breast cancer resistance
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.108304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Xinming Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Breast Neoplasms, Drug Resistance, Neoplasm, RNA, Long Noncoding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shantou University.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are nano-sized particles secreted by many cell types-including tumor cells-and play key roles in cellular communication by transporting functional RNAs. This study aims to elucidate the role of long noncoding RNA BRAF-activated nonprotein coding RNA (BANCR) in EVs derived from breast cancer (BC) cells in trastuzumab resistance. Differentially expressed long noncoding RNA and downstream targets in BC-resistant samples were identified. SKBR-3 cells were treated with trastuzumab to generate resistant cells (SKBR-3TR), and EVs from these cells (SKBR-3TR-EVs) were isolated and characterized. Functional studies of BANCR were performed in SKBR-3 and SKBR-3TR cells. Coculturing SKBR-3 cells with SKBR-3TR-EVs assessed changes in cell behavior. A xenograft model in nude mice examined in vivo tumorigenicity and trastuzumab resistance. BANCR was highly expressed in SKBR-3TR cells and EVs, linked to trastuzumab resistance. SKBR-3TR-EVs transferred BANCR to SKBR-3 cells, where BANCR inhibited miR-34a-5p, reducing its expression. High-mobility group A1 (HMGA1) was identified as a miR-34a-5p target. BANCR activated the HMGA1/Wnt/β-catenin pathway by inhibiting miR-34a-5p, promoting resistance. In vivo experiments showed that BANCR inhibition delayed tumorigenesis and reversed trastuzumab resistance. BC cell-derived EVs containing BANCR may enhance resistance to trastuzumab by regulating the miR-34a-5p/HMGA1/Wnt/β-catenin axis, presenting a potential target for BC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
- Department of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Electronic address: linjing@fahostumc.com.
Förderung
- Shantou University
Zitieren
APA
Song, X., Liu, S., Zeng, Y., Cai, Y., & Luo, H. (2025). BANCR-containing extracellular vesicles enhance breast cancer resistance. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108304
Vancouver
Song X, Liu S, Zeng Y, Cai Y, Luo H. BANCR-containing extracellular vesicles enhance breast cancer resistance. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108304
BibTeX
@article{Song2025,
author = {Song, Xinming and Liu, Shen and Zeng, Ying and Cai, Yilin and Luo, Haiqing},
title = {BANCR-containing extracellular vesicles enhance breast cancer resistance},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.108304}
}
EUVIMED